Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Tarsus Pharmaceuticals Inc stock

Learn how to easily invest in Tarsus Pharmaceuticals Inc stock.

Tarsus Pharmaceuticals Inc is a biotechnology business based in the US. Tarsus Pharmaceuticals Inc shares (TARS) are listed on the NASDAQ and all prices are listed in US Dollars. Tarsus Pharmaceuticals Inc employs 46 staff and has a trailing 12-month revenue of around $17.4 million.

How to buy shares in Tarsus Pharmaceuticals Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TARS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Tarsus Pharmaceuticals Inc stock price (NASDAQ: TARS)

Use our graph to track the performance of TARS stocks over time.

Tarsus Pharmaceuticals Inc shares at a glance

Information last updated 2022-09-25.
Latest market close$16.01
52-week range$10.80 - $31.00
50-day moving average $15.94
200-day moving average $17.18
Wall St. target price$53.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.15

Buy Tarsus Pharmaceuticals Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tarsus Pharmaceuticals Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tarsus Pharmaceuticals Inc price performance over time

Historical closes compared with the close of $16.01 from 2022-09-23

1 week (2022-09-19) 2.83%
1 month (2022-08-26) 6.73%
3 months (2022-06-24) 4.30%
6 months (2022-03-25) -7.67%
1 year (2021-09-24) -29.72%
2 years (2020-09-22) N/A
3 years (2019-09-22) N/A
5 years (2017-09-22) N/A

Tarsus Pharmaceuticals Inc financials

Revenue TTM $17.4 million
Gross profit TTM $13.2 million
Return on assets TTM -15.04%
Return on equity TTM -27.31%
Profit margin 0%
Book value $8.31
Market capitalisation $426.8 million

TTM: trailing 12 months

Tarsus Pharmaceuticals Inc share dividends

We're not expecting Tarsus Pharmaceuticals Inc to pay a dividend over the next 12 months.

Tarsus Pharmaceuticals Inc overview

Tarsus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Frequently asked questions

What percentage of Tarsus Pharmaceuticals Inc is owned by insiders or institutions?
Currently 13.234% of Tarsus Pharmaceuticals Inc shares are held by insiders and 75.335% by institutions.
How many people work for Tarsus Pharmaceuticals Inc?
Latest data suggests 46 work at Tarsus Pharmaceuticals Inc.
When does the fiscal year end for Tarsus Pharmaceuticals Inc?
Tarsus Pharmaceuticals Inc's fiscal year ends in December.
Where is Tarsus Pharmaceuticals Inc based?
Tarsus Pharmaceuticals Inc's address is: 15440 Laguna Canyon Road, Irvine, CA, United States, 92618
What is Tarsus Pharmaceuticals Inc's ISIN number?
Tarsus Pharmaceuticals Inc's international securities identification number is: US87650L1035

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site